1. WCG Appoints Two New Independent Directors to its Board

    WCG Appoints Two New Independent Directors to its Board

    PRINCETON, N.J. , Nov. 2, 2020 /PRNewswire/ -- WCG today announced the appointment of two new independent members to its Board of Directors: Dr. Kavita Patel , a non-resident fellow with the Brookings Institution and a practicing physician, and Pascale Witz , a former senior pharmaceutical executive who has broad corporate board experience...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

    1. These appointments provide important new perspectives to our Board as the company continues to write the next exciting chapter of our evolution.
    2. Dr. Patel's national healthcare policy expertise will bring an important new dimension to our strategic direction as we seek to improve drug development by closing the operational gaps between clinical research and clinical care.
    3. Ms. Witz's broad cross-functional and global experience in the biopharmaceutical industry will help WCG and its clients successfully navigate the political and financial challenges facing the life sciences industry.
  3. Topics Mentioned